Advertisement
Loading...

Moolec Science S.A.

MLECNASDAQ
Healthcare
Biotechnology
$8.21
$-0.58(-6.60%)
U.S. Market is Open • 12:42

MLEC News Today: Stay Updated with the Latest Moolec Science S.A. News in Real Time

Find MLEC news now at Meyka AI. Stay informed with the latest Moolec Science S.A. stocks updates, including price news, market analysis, and expert insights.

MRK.DE Merck KGaA Earnings Beat: EPS Tops Estimates
📅 in about 4 hours

MRK.DE Merck KGaA Earnings Beat: EPS Tops Estimates

Merck KGaA beats EPS estimates with $2.08 actual vs $1.97 expected. Revenue misses slightly at $5.05B. Stock up 6.6%.

Read more
Poland Space Economy May 14: Astronaut Drives Growth
📅 in about 4 hours

Poland Space Economy May 14: Astronaut Drives Growth

Astronaut Sławosz Uznański-Wiśniewski discusses Poland’s ISS mission and aerospace growth at Impact’26 conference.

Read more
MLEC Director Core Daniel Joaquin Files Initial Ownership, May 14, 2026
📅 in about 3 hours

MLEC Director Core Daniel Joaquin Files Initial Ownership, May 14, 2026

Director Core Daniel Joaquin files initial ownership of 933 MLEC shares valued at $6,661.62 on April 15, 2026.

Read more
Bosera STAR 50 Index ETF Surges 36.1% as Tech Innovation Gains Momentum
📅 3 hours ago

Bosera STAR 50 Index ETF Surges 36.1% as Tech Innovation Gains Momentum

82832.HK stock jumps 36.1% to HK$11.12 on strong tech sector performance. Bosera STAR 50 Index ETF tracks SSE STAR Board innovation leaders.

Read more
Mark Pathy Donates $15M to Concordia May 13: Space Institute Launch
📅 11 hours ago

Mark Pathy Donates $15M to Concordia May 13: Space Institute Launch

Mark Pathy donates $15M to Concordia University to launch Space Institute, advancing space research and engineering education.

Read more
CTEV Maintained at Buy by Citigroup, May 2026
📅 14 hours ago

CTEV Maintained at Buy by Citigroup, May 2026

Citigroup maintains Buy rating on Claritev (CTEV), raises price target to $40 from $21 on May 13, 2026.

Read more
BAYRY Bayer AG Earnings Beat: EPS Crushes Estimates by 25%
📅 15 hours ago

BAYRY Bayer AG Earnings Beat: EPS Crushes Estimates by 25%

Bayer AG (BAYRY) beat EPS estimates by 24.69% with $0.798 actual vs $0.64 expected. Revenue slightly beat at $15.79B.

Read more
OncoTherapy Science (4564.T) Faces Headwinds as Biotech Stock Slides 12.5% in Five Days
📅 20 hours ago

OncoTherapy Science (4564.T) Faces Headwinds as Biotech Stock Slides 12.5% in Five Days

4564.T stock drops 12.5% over five days amid clinical trial pipeline challenges. Meyka AI rates the biotech firm with a B grade.

Read more
BAYN.SW Bayer AG Earnings Beat: EPS Crushes Estimates
📅 21 hours ago

BAYN.SW Bayer AG Earnings Beat: EPS Crushes Estimates

Bayer AG (BAYN.SW) beat EPS estimates by 17.37% with $2.50 actual vs $2.13 expected, but revenue missed slightly at $12.38B.

Read more

MLEC News FAQ